Post-approval studies (Phase 4)WithdrawnNCT00242528
What this trial is testing
Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.
Who this might be right for
Multiple Myeloma
Novartis